Immunohistochemistry as a reliable predictor of remission in patients with endometrial cancer: Establishment and validation of a machine learning model.
Ontology highlight
ABSTRACT: Endometrial cancer (EC) is the most common gynecologic cancer. Unfortunately, its prognosis remains poor due to limited screening and treatment options. To address this issue, the present study evaluated the predictive value of four immunohistochemical (IHC) indicators for overall survival (OS) and recurrence-free survival (RFS) in patients with EC. A total of 834 patients diagnosed with EC were included at Peking University People's Hospital between January 2006 and December 2020. These patients were randomly divided into training and validation cohorts at a 2:1 ratio, collecting data on clinicopathological information and IHC indicators. A total of 92 combinations of algorithms were assessed using the Leave-One-Out Cross-Validation framework to identify the one with the highest C-index.
SUBMITTER: Wang R
PROVIDER: S-EPMC11599912 | biostudies-literature | 2025 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA